NCT00453492View on ClinicalTrials.gov

Risedronate Sodium in Post Menopausal Osteoporosis

PHASE4CompletedINTERVENTIONAL

Enrollment

246

Participants

Timeline

Start Date

January 31, 2004

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

risedronate sodium

Trial Locations (1)

Unknown

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Procter and Gamble

INDUSTRY

lead

Sanofi

INDUSTRY